From: Clinical characteristics and drug resistance of Nocardia in Henan, China, 2017–2023
Characteristics | Bronchiectasis | Non bronchiectasis | P value* |
---|---|---|---|
(n = 39)a | (n = 29)a | ||
Nocardia species identifification | |||
N.cyriacigeorgica | 9 (23.1%) | 3 (10.3%) | 0.173 |
N.abscessus | 8 (20.5%) | 0 (0%) | 0.017 |
N.farcinica | 6 (15.4%) | 12 (41.4%) | 0.016 |
N.amamiensis | 6 (15.4%) | 2 (6.9%) | 0.451 |
N.otitidiscaviarum | 4 (10.3%) | 1 (3.4%) | 0.384 |
N.beijingensis | 2 (5.1%) | 3 (10.3%) | 0.644 |
N.asiatica | 1 (2.6%) | 2 (6.9%) | 0.571 |
N.puris | 1 (2.6%) | 0 (0%) | 1.000 |
N. wallacei | 1 (2.6%) | 2 (6.9%) | 0.571 |
N.pseudobrasiliensis | 1 (2.6%) | 0 (0%) | 1.000 |
N.flavorosea | 0 (0%) | 1 (3.4%) | 0.426 |
N.rhamnosiphila | 0 (0%) | 1 (3.4%) | 0.426 |
N.africana | 0 (0%) | 2 (6.9%) | 0.178 |
Antibiotic resistance profifiles | |||
AUG | 14 (35.9%) | 10 (34.5%) | 0.904 |
Ceftriaxone | 9 (23.1%) | 15 (51.7%) | 0.014 |
Imipenem | 14 (35.9%) | 12(41.4%) | 0.645 |
Tobramycin | 3 (7.7%) | 13 (44.8%) | 0.000 |
Ciprofloxacin | 25 (64.1%) | 12 (41.4%) | 0.063 |
Moxifloxacin | 11 (28.2%) | 10 (34.5%) | 0.799 |
Amikacin | 0 (0%) | 1 (3.4%) | 0.426 |
Linezolid | 0 (0%) | 0 (0%) | > 1.000 |
TMP-SMX | 0 (0%) | 0 (0%) | > 1.000 |
Clarithromycin | 16 (41%) | 15 (51.7%) | 0.381 |
Doxycycline | 1(2.6%) | 0 (0%) | 1.000 |
Minocycline | 1 (2.6%) | 0 (0%) | 1.000 |